Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Bita Motesharrei

Obstetrics Mc Lean, VA Medical Doctor

NPI 1164496675 CMS profile 52197

1515 Chain Bridge Rd, Suite 314, Mc Lean, VA 22101

Open in the dashboard

General payments

$3,879

178 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Bita Motesharrei of Mc Lean, VA is reported in the CMS Open Payments database as having received $3,879 across 178 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 85th percentile of Obstetrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $686 33
2024 General $577 27
2023 General $829 31
2022 General $588 31
2021 General $671 27
2020 General $188 11
2019 General $340 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bita Motesharrei
  • Obstetrics median
  • Middle half of Obstetrics
  • National median

In program year 2025, general payments to Bita Motesharrei were reported at $686. Among 649 Obstetrics profiles paid that year, the median was $181 and the middle half received between $61 and $424.

Show as a table
Year Bita Motesharrei Obstetrics median Middle half National median
2019 $340 $177 $60–$381 $163
2020 $188 $92 $35–$201 $114
2021 $671 $125 $40–$351 $132
2022 $588 $186 $65–$448 $149
2023 $829 $183 $61–$451 $160
2024 $577 $176 $62–$406 $164
2025 $686 $181 $61–$424 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Mayne Pharma Inc. $595 32 payments
  2. AbbVie, Inc. $521 26 payments
  3. Sumitomo Pharma America, Inc. $309 16 payments
  4. Astellas Pharma US Inc $295 9 payments
  5. Renovia Inc $243 3 payments
  6. Vermillion, Inc. $185 7 payments
  7. Exeltis, USA Inc. $167 8 payments
  8. TherapeuticsMD, Inc. $148 8 payments
  9. Evofem Biosciences, Inc. $147 8 payments
  10. Millicent US Inc $140 7 payments
  11. Other $1,130 54 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,804 173 payments
  2. Education $76 5 payments
Products named General payments · program years 2019–2025
  1. MYFEMBREE $323 17 payments
  2. Veozah $312 10 payments
  3. Leva Pelvic Floor Trainer $243 3 payments
  4. ORILISSA Womens Health $201 10 payments
  5. OVA1 $185 7 payments
  6. LO LOESTRIN FE $165 9 payments
  7. Orilissa Endocrinology $157 7 payments
  8. Phexxi $147 8 payments
  9. ORIAHNN $142 8 payments
  10. PREMARIN $117 6 payments
  11. Other $2,062 101 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

178 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record